VK2735
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Viking Therapeutics · Phase 3 · Active, not recruiting · Enrollment 1100
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Placebo Assignment | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #1) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #2) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #3) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.